Ceradyne (CRDN) Lowers FY09 Sales Guidance, Reiterates FY10

January 11, 2010 7:40 AM EST Send to a Friend
Ceradyne, Inc. (Nasdaq: CRDN) announced preliminary unaudited results for FY09.

Sees sales of about $401 million, which compares to ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login